Antibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinoma.

2.50
Hdl Handle:
http://hdl.handle.net/10541/85588
Title:
Antibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinoma.
Authors:
Connolly, Yvonne; Littler, Edward; Sun, Ning; Chen, Xiaoyi; Huang, Per-Chun; Stacey, Simon N; Arrand, John R
Abstract:
Patients suffering from nasopharyngeal carcinoma (NPC) generally exhibit elevated serum IgA antibody titres to Epstein-Barr virus (EBV) early antigen (EA) and virus capsid antigen (VCA). This property is frequently used as a diagnostic aid. Preliminary experiments suggested that an ELISA for IgA antibodies against the EBV-encoded thymidine kinase (TK) could form the basis of a more reliable diagnostic test. Here, we describe the construction of a recombinant baculovirus that expresses the EBV TK and present a full analysis of its use in serological surveys of NPC patients. Baculovirus-derived TK was used to develop a simple ELISA for serum IgA against this antigen. ELISA reactivity was strongly associated with NPC compared with an EBV-positive, normal control population. Comparison with the existing IgA-VCA and EA assays showed that the TK ELISA had higher sensitivity whilst the specificity was similar or higher. We conclude that the TK ELISA presents a strong predictor of NPC and, in its refined form, has improved pickup rates. In addition, results from patients with chronic nasopharyngitis (CNP) suggest that individuals with both symptoms of CNP and an elevated TK ELISA value may be at increased risk for the development of head-and-neck cancer.
Affiliation:
Paterson Institute for Cancer Research, Christie CRC Research Centre, Manchester, United Kingdom.
Citation:
Antibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinoma. 2001, 91 (5):692-7 Int. J. Cancer
Journal:
International Journal of Cancer.
Issue Date:
1-Mar-2001
URI:
http://hdl.handle.net/10541/85588
PubMed ID:
11267982
Type:
Article
Language:
en
ISSN:
0020-7136
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorConnolly, Yvonneen
dc.contributor.authorLittler, Edwarden
dc.contributor.authorSun, Ningen
dc.contributor.authorChen, Xiaoyien
dc.contributor.authorHuang, Per-Chunen
dc.contributor.authorStacey, Simon Nen
dc.contributor.authorArrand, John Ren
dc.date.accessioned2009-11-06T16:30:03Z-
dc.date.available2009-11-06T16:30:03Z-
dc.date.issued2001-03-01-
dc.identifier.citationAntibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinoma. 2001, 91 (5):692-7 Int. J. Canceren
dc.identifier.issn0020-7136-
dc.identifier.pmid11267982-
dc.identifier.urihttp://hdl.handle.net/10541/85588-
dc.description.abstractPatients suffering from nasopharyngeal carcinoma (NPC) generally exhibit elevated serum IgA antibody titres to Epstein-Barr virus (EBV) early antigen (EA) and virus capsid antigen (VCA). This property is frequently used as a diagnostic aid. Preliminary experiments suggested that an ELISA for IgA antibodies against the EBV-encoded thymidine kinase (TK) could form the basis of a more reliable diagnostic test. Here, we describe the construction of a recombinant baculovirus that expresses the EBV TK and present a full analysis of its use in serological surveys of NPC patients. Baculovirus-derived TK was used to develop a simple ELISA for serum IgA against this antigen. ELISA reactivity was strongly associated with NPC compared with an EBV-positive, normal control population. Comparison with the existing IgA-VCA and EA assays showed that the TK ELISA had higher sensitivity whilst the specificity was similar or higher. We conclude that the TK ELISA presents a strong predictor of NPC and, in its refined form, has improved pickup rates. In addition, results from patients with chronic nasopharyngitis (CNP) suggest that individuals with both symptoms of CNP and an elevated TK ELISA value may be at increased risk for the development of head-and-neck cancer.en
dc.language.isoenen
dc.subjectNasopharyngeal Canceren
dc.subjectBiological Tumour Markersen
dc.subject.meshAnimals-
dc.subject.meshAntibodies-
dc.subject.meshBaculoviridae-
dc.subject.meshCarcinoma-
dc.subject.meshCell Line-
dc.subject.meshEnzyme-Linked Immunosorbent Assay-
dc.subject.meshHerpesvirus 4, Human-
dc.subject.meshHumans-
dc.subject.meshImmunoglobulin A-
dc.subject.meshInsects-
dc.subject.meshMicroscopy, Fluorescence-
dc.subject.meshNasopharyngeal Neoplasms-
dc.subject.meshNasopharyngitis-
dc.subject.meshPilot Projects-
dc.subject.meshRisk Factors-
dc.subject.meshThymidine Kinase-
dc.subject.meshTime Factors-
dc.subject.meshTumor Markers, Biological-
dc.titleAntibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinoma.en
dc.typeArticleen
dc.contributor.departmentPaterson Institute for Cancer Research, Christie CRC Research Centre, Manchester, United Kingdom.en
dc.identifier.journalInternational Journal of Cancer.en

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.